The global veterinary dermatology drugs market accounted US$7.8 Bn in 2020 with a significant CAGR of 9.6% during the forecast period of 2021 to 2028.
Veterinary dermatology deals with the expertise in diagnosing and treating various skin disorders in animals such as skin, ear, hair, nail, hoof, and mouth.
Growth Factors
Rising prevalence of diseases among animals results in the growth of global veterinary dermatology drugs market
According to the Food and Agriculture Organization (FAO), lumpy skin disease (LSD) is an economically significant cattle disease that can cause persistent weakness in infected livestock as compared to that caused by foot-and-mouth disease (FMD). Mortality rates of up to 40% or more have been reported, with severe and permanent damage to hides resulting in skin lesions. Lesions in the mouth, pharynx and respiratory tract are common, resulting in rapid deterioration and, in some cases, severe emaciation that can last for months. There is currently no specific antiviral treatment available for LSD infection in cattle. However, two vaccines for Neethling and Kenya sheep and goat pox virus have been widely used in Africa and have achieved great success in the global market. The aforementioned factors have become critical for the expansion of the global veterinary dermatology drugs market.
Report coverage
| Market |
Veterinary Dermatology Drugs Market |
| Analysis Period |
2017 - 2028 |
| Base Year |
2020 |
| Forecast Data |
2021 - 2028 |
| Segments Covered |
By Animal Type, By Route of Administration, By Indication, By Distribution Channel, and By Geography |
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Elanco Animal Health, Vetoquinol SA, Ceva, Intervet Inc., a subsidiary of Merck & Co. Inc., Zoetis, Virbac, Bimeda, Inc., Vivaldis, and among others.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
| Customization Scope |
10 hrs of free customization and expert consultation
|
Rising pet owners resulting in fuelling pet care decisions propel the growth of global market
According to the 2019-2020 National Pet Owners Survey conducted by the American Pet Products Association, 67% of US households, or approximately 85 million families, own a pet, according to the Insurance Information Institute, Inc. report (APPA). This compares to a 56% increase among US households in the first survey, which was conducted in 1988. Furthermore, according to the Insurance Research Council's 2020 Report, nearly one-third (30%) of Americans adopted a pet at the time of COVID-19. The National Association of Insurance Commissioners (NAIC) established the Pet Insurance Working Group in 2020, with the goal of developing a model law that would create a stronger regulatory framework for pet insurance across the United States. Such factors have a positive impact on the global veterinary dermatology drugs market.
Key trends
The quintessential factors of pet insurance driving all time high veterinary dermatology drugs market
According to the North American Pet Health Insurance Association (NAPHIA), the pet health insurance sector in the United States increased its gross written premiums by 27.5 percent to US$1.9 billion in 2020 from US$1.5 billion in 2019. In 2020, dogs accounted for 83 percent of in-force gross written premiums. According to NAPHIA, the average annual premium for dog insurance in 2020 was US$218 for accident-only coverage, which included care for foreign body ingestion, laceration, motor vehicle accidents, poisoning, and other injuries. The average annual premium for accident and illness insurance was $594, which covered accident-only benefits as well as illnesses such as cancer, infections, digestive problems, and other illnesses.
Market Segmentation
The global veterinary dermatology drugs market is segmented based on animal type, route of administration, indication, and distribution channel. By animal type, the market is split into companion animal and livestock animal. By route of administration, the market is segregated as oral, topical, and injectable. By indication, the market is segmented as parasitic infection, allergic infection, and others. Furthermore, distribution channel is segmented as retail, e-commerce, and hospital pharmacies.
Based on route of administration, oral segment dominated the market accounting maximum share during the analysis period of 2021 to 2028
According to the Hopkins report, combining two drugs already approved by the US Food and Drug Administration (USFDA) for different applications reduces wound healing and significantly reduces scar tissue in mice and rats. Furthermore, dual treatment is a promising technique for accelerating wound healing in animals with skin ulcers, extensive burns, surgical wounds, and battlefield injuries. This is one of the key drivers of segmental growth, which ultimately contributes to the overall veterinary dermatology drugs market.
In terms of indication, the parasitic infection segment contributes to the overall growth of the veterinary dermatology drug market. As parasites are responsible for some of the most serious and well-known zoonotic infectious diseases transmitted from companion animals to humans around the world. Zoonotic parasitic infections, for example, are a major global public and veterinary health issue spread by stray dogs. For the record, dogs were found to be infected with a single genus of intestinal parasites at a rate of 18.7%. These factors have a positive impact on segmental growth, which ultimately contributes to the overall growth of the veterinary dermatology drugs market.
Regional Overview
North America dominates the veterinary dermatology drugs market; Asia Pacific registers fastest growing CAGR during the projected period of 2021 to 2028
Because of the presence of top companies involved in providing valuable treatment, North America holds the dominant share of the veterinary dermatology drugs market. Animal Dermatology Group, Inc. (ADG), for example, is a privately held US veterinary dermatology specialty company with the world's largest group of veterinary dermatology specialists specializing in the diagnosis and treatment of acute and chronic skin conditions in pets. ADG currently has over 38 veterinarians active in clinical care, research, and academic training to advance the field of veterinary dermatology.
Asia Pacific, on the other hand, is expected to have the fastest growing CAGR for the veterinary dermatology drugs market from 2021 to 2028. During the forecast period of 2021 to 2028, the Asia Pacific region's market for veterinary dermatology drugs is expected to grow at a faster rate. This is due to increased awareness of available veterinary treatment options, as well as the hub for manufacturing facilities of veterinary dermatology drug companies like Elanco. This is one of the most important factors influencing the APAC regional market for veterinary dermatology drugs.
Competitive Landscape
The prominent players of the global veterinary dermatology drugs market involve Elanco Animal Health, Vetoquinol SA, Ceva, Intervet Inc., a subsidiary of Merck & Co. Inc., Zoetis, Virbac, Bimeda, Inc., Vivaldis, and among others.
Market Segmentation
Market By Animal Type
Market By Route of Administration
Market By Indication
- Parasitic Infections
- Allergic Infections
- Others
Market By Distribution Channel
- Retail
- E-Commerce
- Hospital Pharmacies
Market By Geography
- North America
- Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Veterinary Dermatology Drugs
1.1. Definition and Scope
1.1.1. Definition of Veterinary Dermatology Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Veterinary Dermatology Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Veterinary Dermatology Drugs Market By Animal Type
1.2.3. Veterinary Dermatology Drugs Market By Route Of Administration
1.2.4. Veterinary Dermatology Drugs Market By Indication
1.2.5. Veterinary Dermatology Drugs Market By Distribution Channel
1.2.6. Veterinary Dermatology Drugs Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2020
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Veterinary Dermatology Drugs Market By Animal Type
4.1. Introduction
4.2. Veterinary Dermatology Drugs Revenue By Animal Type
4.2.1. Veterinary Dermatology Drugs Revenue (US$ Mn) and Forecast, By Animal Type, 2017-2028
4.2.2. Companion Animal
4.2.2.1. Companion Animal Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
4.2.3. Livestock Animal
4.2.3.1. Livestock Animal Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 5. Veterinary Dermatology Drugs Market Revenue By Route Of Administration
5.1. Introduction
5.2. Veterinary Dermatology Drugs Revenue (US$ Mn) By Route Of Administration
5.2.1. Veterinary Dermatology Drugs Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
5.2.2. Oral
5.2.2.1. Oral Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3. Topical
5.2.3.1. Topical Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4. Injectable
5.2.4.1. Injectable Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6. Veterinary Dermatology Drugs Market By Indication
6.1. Introduction
6.2. Veterinary Dermatology Drugs Revenue (US$ Mn) By Indication
6.2.1. Veterinary Dermatology Drugs Revenue (US$ Mn) and Forecast By Indication, 2017-2028
6.2.2. Parasitic Infections
6.2.2.1. Parasitic Infections Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3. Allergic Infections
6.2.3.1. Allergic Infections Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4. Others
6.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7. Veterinary Dermatology Drugs Market By Distribution Channel
7.1. Introduction
7.2. Veterinary Dermatology Drugs Revenue (US$) By Distribution Channel
7.2.1. Veterinary Dermatology Drugs Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
7.3. Retail
7.3.1. Retail Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.4. E-Commerce
7.4.1. E-Commerce Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.5. Hospital Pharmacies
7.5.1. Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8. North America Veterinary Dermatology Drugs Market By Country
8.1. North America Veterinary Dermatology Drugs Overview
8.2. U.S.
8.2.1. U.S. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
8.2.2. U.S. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
8.2.3. U.S. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
8.2.4. U.S. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
8.3. Canada
8.3.1. Canada Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
8.3.2. Canada Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
8.3.3. Canada Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
8.3.4. Canada Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
8.4. North America PEST Analysis
CHAPTER 9. Europe Veterinary Dermatology Drugs Market By Country
9.1. Europe Veterinary Dermatology Drugs Market Overview
9.2. U.K.
9.2.1. U.K. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
9.2.2. U.K. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
9.2.3. U.K. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.2.4. U.K. Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.3. Germany
9.3.1. Germany Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
9.3.2. Germany Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
9.3.3. Germany Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.3.4. Germany Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.4. France
9.4.1. France Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
9.4.2. France Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
9.4.3. France Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.4.4. France Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.5. Spain
9.5.1. Spain Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
9.5.2. Spain Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
9.5.3. Spain Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.5.4. Spain Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.6. Rest of Europe
9.6.1. Rest of Europe Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
9.6.2. Rest of Europe Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
9.6.3. Rest of Europe Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.6.4. Rest of Europe Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Veterinary Dermatology Drugs Market By Country
10.1. Asia Pacific Veterinary Dermatology Drugs Market Overview
10.2. China
10.2.1. China Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
10.2.2. China Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
10.2.3. China Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.2.4. China Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
10.3. Japan
10.3.1. Japan Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
10.3.2. Japan Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
10.3.3. Japan Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.3.4. Japan Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
10.4. India
10.4.1. India Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
10.4.2. India Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
10.4.3. India Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.4.4. India Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
10.5. Australia
10.5.1. Australia Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
10.5.2. Australia Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
10.5.3. Australia Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.5.4. Australia Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
10.6. South Korea
10.6.1. South Korea Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
10.6.2. South Korea Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
10.6.3. South Korea Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.6.4. South Korea Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
10.7.2. Rest of Asia-Pacific Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
10.7.3. Rest of Asia-Pacific Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.7.4. Rest of Asia-Pacific Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Veterinary Dermatology Drugs Market By Country
11.1. Latin America Veterinary Dermatology Drugs Market Overview
11.2. Brazil
11.2.1. Brazil Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
11.2.2. Brazil Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
11.2.3. Brazil Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.2.4. Brazil Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
11.3. Mexico
11.3.1. Mexico Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
11.3.2. Mexico Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
11.3.3. Mexico Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.3.4. Mexico Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
11.4. Rest of Latin America
11.4.1. Rest of Latin America Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
11.4.2. Rest of Latin America Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
11.4.3. Rest of Latin America Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.4.4. Rest of Latin America Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Veterinary Dermatology Drugs Market By Country
12.1. Middle East & Africa Veterinary Dermatology Drugs Market Overview
12.2. GCC
12.2.1. GCC Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
12.2.2. GCC Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
12.2.3. GCC Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
12.2.4. GCC Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
12.3. South Africa
12.3.1. South Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
12.3.2. South Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
12.3.3. South Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
12.3.4. South Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Animal Type, 2017-2028
12.4.2. Rest of Middle East & Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Route Of Administration, 2017-2028
12.4.3. Rest of Middle East & Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
12.4.4. Rest of Middle East & Africa Veterinary Dermatology Drugs Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Veterinary Dermatology Drugs
13.1. Veterinary Dermatology Drugs Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Veterinary Dermatology Drugs Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Elanco Animal Health
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2020
14.1.3.2. Elanco Animal Health 2020 Veterinary Dermatology Drugs Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Vetoquinol SA
14.3. Ceva
14.4. Intervet Inc., a subsidiary of Merck & Co. Inc.
14.5. Zoetis
14.6. Virbac
14.7. Bimeda, Inc.
14.8. Vivaldis
14.9. Others
